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The amoeba Naegleria fowleri causes Primary Amoebic Meningoencephalitis (PAM), a 33 rapidly fatal disease of the central nervous system (CNS) (1) (2) (3) . N. fowleri is one of the three 34 most common free-living amoebae that can infect humans, the others being Acanthamoeba 35 spp. and Balamuthia mandrillaris. These amoebae are ubiquitously present, with N. fowleri 36 reported on all continents, except Antarctica (4). N. fowleri infections occur mostly in healthy 37 children and young adults during recreational water activities, such as swimming, diving and 38 rafting (5, 6). When water containing N. fowleri makes contact with the nasal epithelium, the 39 trophozoite stage of the amoeba can migrate along the olfactory nerve, through the cribriform 40 plate to the olfactory bulb within the CNS (2, 3, 7). Once inside the brain, the trophozoites 41 will cause necrosis and acute inflammation, ultimately leading to death in over 95% of the 42 cases (1, 3). There is concern that global warming and changes in the ecosystems that N. 43 fowleri inhabits, may lead to more cases worldwide (8, 9) . A wide range of antifungals and 
47
Inhibition of metabolic processes essential to microorganisms is a fruitful strategy for 48 the development of effective drugs (11). Several widely used drugs target the metabolism of 49 the pathogen to exert their killing effect, such as the antimalarials atovaquone and proguanil, 50 and the broad-spectrum antihelminthic and antiprotozoal nitazoxanide (12, 13).
51
Previous research by our group showed that N. gruberi, a close relative to N. fowleri,
52
prefers fatty acids as a food source (14). This led us to the hypothesis that inhibiting fatty acid 53 oxidation (FAO) could inhibit growth or even kill the amoeba. We identified several drugs 54 that inhibit fatty acid metabolism in different parts of this pathway. As the metabolic 55 machinery of N. gruberi is highly similar to that of N. fowleri (14-16), we used N. gruberi as a 56 4 model organism to determine the effects of these compounds. We then compared the effects 57 of these inhibitors to the currently used treatment (AMB and MIL) and determined additive 58 effects of the compounds when they were combined. 
Results
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Initially, a wide range of concentrations of all investigated compounds was used to estimate 
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Addition of PHX resulted in an inhibition of about 50% in most concentrations (Fig. 1B) .
95
ETO addition resulted in clear inhibition at concentrations above 600 µM ( was a difference in the capacity for regrowth after exposure to the different compounds. with VPA, regrowth capacity was reduced substantially (Fig. 3C) . To assess viability of the 130 amoeba, pictures were recorded at day 0, 5 and pictures and movies were recorded at day 14, 131 7 which is 9 days after removal of the drugs (supplementary material). At day 5 after washing,
132
only active trophozoites were seen in the wells with a single drug exposure (Fig S2 A-D) . In 133 contrast, only rounded immobile amoeba were visible in the wells with AMB + ETO and 134 AMB + PHX (Fig. S3 A-B) . We noticed one single trophozoite besides the many rounded 135 amoeba in the wells with AMB + VPA (Fig. S3 C) . At day 14 the amoeba incubated with 136 AMB + ETO, AMB + PHX or AMB + VPA showed only rounded and disfigured amoeba 137 ( Fig. S4 A-C triplicate.
